CANCER RESEARCH & TREATMENT FUND INC

aka CR&T | New York, NY | https://www.crt.org

GuideStar Charity Check

EIN: 13-6272085

Contributions tax deductible
as of September 2023

IRS BMF 509(a)(1)
as of September 18, 2023

View summary

Charity Check report

Mission

The mission of Cancer Research & Treatment Fund (CR&T) is to fund research that will lead to new therapies and cures for cancer, with a particular focus on blood cancer, especially the myelproliferative neoplasms (MPN). CR&T sponsored investigators have also contributed to advances in breast, lung, and prostate cancer. For more information, please visit www.crt.org.

Ruling year info

1968

President

Thomas M. Silver

Main address

500 E 77th St Ste 1001

New York, NY 10162 USA

Show more contact info

EIN

13-6272085

Subject area info

Cancers

Population served info

Chronically ill people

NTEE code info

Cancer Research (H30)

IRS subsection

501(c)(3) Public Charity

IRS filing requirement

This organization is required to file an IRS Form 990 or 990-EZ.

Tax forms

Show Forms 990

Communication

Programs and results

What we aim to solve

This profile needs more info.

If it is your nonprofit, add a problem overview.

Our programs

SOURCE: Self-reported by organization

What are the organization's current programs, how do they measure success, and who do the programs serve?

Grantmaking

CR&T Provides resources for state-of-the-art research that leads to effective treatment of cancers, with a particular focus on blood cancers, including myeloproliferative neoplasms (MPN).

Population(s) Served

Chronically ill people

Where we work

External reviews

Financials

CANCER RESEARCH & TREATMENT FUND INC

Fiscal year: Jan 01 - Dec 31

Financial documents

Yes, financials were audited by an independent accountant.

Revenue vs. expenses: breakdown

SOURCE: IRS Form 990

NET GAIN/LOSS: in

Note: When component data are not available, the graph displays the total Revenue and/or Expense values.

Liquidity in 2021

SOURCE: IRS Form 990

5.04

Average of 27.32 over 10 years

Months of cash in 2021

SOURCE: IRS Form 990

14.2

Average of 11.9 over 10 years

Fringe rate in 2021

SOURCE: IRS Form 990

9%

Average of 11% over 10 years

Funding sources

Source: IRS Form 990

Assets & liabilities

Source: IRS Form 990

Financial data

SOURCE: IRS Form 990

Digitizing IRS form 990 data

CANCER RESEARCH & TREATMENT FUND INC

Revenue & expenses

Fiscal Year: Jan 01 - Dec 31

SOURCE: IRS Form 990 info

Fiscal year ending: Download Data

Revenue
Contributions	$254,704
Government Grants	$0
Program Services	$0
Investments	$335,445
Special Events	$170,424
Sales	$0
Other	$0
Total Revenue	$760,573

Expenses
Program Services	$796,148
Administration	$195,947
Fundraising	$132,422
Total Expenses	$1,124,517
Net Gain/Loss	($363,944)

Functional expenses
Accounting Fees	$19,750
Advertising & Promotion	$0
Information Technology Expenses	$0
Insurance Expenses	$0
Interest Expenses	$0
Investment Management Fees	$0
Legal Fees	$0
Pension Plan Contributions	$0
Professional Fundraising Expenses	$0

Revenue
Contributions	$185,001
Government Grants	$0
Program Services	$68,318
Investments	$198,795
Special Events	$141,274
Sales	$0
Other	$0
Total Revenue	$593,388

Expenses
Program Services	$764,426
Administration	$66,993
Fundraising	$144,491
Total Expenses	$975,910
Net Gain/Loss	($382,522)

Functional expenses
Accounting Fees	$19,025
Advertising & Promotion	$0
Information Technology Expenses	$0
Insurance Expenses	$0
Interest Expenses	$0
Investment Management Fees	$0
Legal Fees	$0
Pension Plan Contributions	$0
Professional Fundraising Expenses	$0

Revenue
Contributions	$350,635
Government Grants	$0
Program Services	$0
Investments	$575,118
Special Events	$232,789
Sales	$0
Other	$0
Total Revenue	$1,158,542

Expenses
Program Services	$653,815
Administration	$69,683
Fundraising	$147,142
Total Expenses	$870,640
Net Gain/Loss	$287,902

Functional expenses
Accounting Fees	$19,025
Advertising & Promotion	$0
Information Technology Expenses	$0
Insurance Expenses	$0
Interest Expenses	$0
Investment Management Fees	$0
Legal Fees	$0
Pension Plan Contributions	$0
Professional Fundraising Expenses	$0

Revenue
Contributions	$443,805
Government Grants	$0
Program Services	$69,300
Investments	$135,091
Special Events	($85,520)
Sales	$0
Other	$0
Total Revenue	$562,676

Expenses
Program Services	$739,909
Administration	$70,017
Fundraising	$147,862
Total Expenses	$957,788
Net Gain/Loss	($395,112)

Functional expenses
Accounting Fees	$18,000
Advertising & Promotion	$0
Information Technology Expenses	$0
Insurance Expenses	$0
Interest Expenses	$0
Investment Management Fees	$0
Legal Fees	$0
Pension Plan Contributions	$0
Professional Fundraising Expenses	$0

Revenue
Contributions	$528,302
Government Grants	$0
Program Services	$0
Investments	$184,261
Special Events	($83,013)
Sales	$0
Other	$0
Total Revenue	$629,550

Expenses
Program Services	$788,636
Administration	$70,186
Fundraising	$145,781
Total Expenses	$1,004,603
Net Gain/Loss	($375,053)

Functional expenses
Accounting Fees	$18,000
Advertising & Promotion	$0
Information Technology Expenses	$0
Insurance Expenses	$0
Interest Expenses	$0
Investment Management Fees	$0
Legal Fees	$0
Pension Plan Contributions	$0
Professional Fundraising Expenses	$0

Revenue
Contributions	$760,137
Government Grants	$0
Program Services	$0
Investments	$454,362
Special Events	($51,535)
Sales	$0
Other	$0
Total Revenue	$1,162,964

Expenses
Program Services	$676,468
Administration	$71,200
Fundraising	$157,025
Total Expenses	$904,693
Net Gain/Loss	$258,271

Functional expenses
Accounting Fees	$18,000
Advertising & Promotion	$0
Information Technology Expenses	$0
Insurance Expenses	$0
Interest Expenses	$0
Investment Management Fees	$0
Legal Fees	$0
Pension Plan Contributions	$0
Professional Fundraising Expenses	$0

Revenue
Contributions	$758,813
Government Grants	$0
Program Services	$0
Investments	$264,507
Special Events	($68,486)
Sales	$0
Other	$0
Total Revenue	$954,834

Expenses
Program Services	$692,890
Administration	$61,914
Fundraising	$139,309
Total Expenses	$894,113
Net Gain/Loss	$60,721

Functional expenses
Accounting Fees	$12,000
Advertising & Promotion	$0
Information Technology Expenses	$0
Insurance Expenses	$0
Interest Expenses	$0
Investment Management Fees	$0
Legal Fees	$0
Pension Plan Contributions	$0
Professional Fundraising Expenses	$0

Revenue
Contributions	$820,761
Government Grants	$0
Program Services	$0
Investments	$281,348
Special Events	($92,999)
Sales	$0
Other	$0
Total Revenue	$1,009,110

Expenses
Program Services	$1,107,014
Administration	$47,474
Fundraising	$106,813
Total Expenses	$1,261,301
Net Gain/Loss	($252,191)

Functional expenses
Accounting Fees	$12,000
Advertising & Promotion	$0
Information Technology Expenses	$0
Insurance Expenses	$0
Interest Expenses	$0
Investment Management Fees	$0
Legal Fees	$0
Pension Plan Contributions	$0
Professional Fundraising Expenses	$0

Revenue
Contributions	$865,870
Government Grants	$0
Program Services	$0
Investments	$152,210
Special Events	($107,246)
Sales	$0
Other	$0
Total Revenue	$910,834

Expenses
Program Services	$959,799
Administration	$53,084
Fundraising	$119,438
Total Expenses	$1,132,321
Net Gain/Loss	($221,487)

Functional expenses
Accounting Fees	$12,000
Advertising & Promotion	$0
Information Technology Expenses	$0
Insurance Expenses	$0
Interest Expenses	$0
Investment Management Fees	$0
Legal Fees	$0
Pension Plan Contributions	$0
Professional Fundraising Expenses	$0

Revenue
Contributions	$881,420
Government Grants	$0
Program Services	$0
Investments	$328,349
Special Events	($137,272)
Sales	$0
Other	$0
Total Revenue	$1,072,497

Expenses
Program Services	$1,062,286
Administration	$54,239
Fundraising	$122,042
Total Expenses	$1,238,567
Net Gain/Loss	($166,070)

Functional expenses
Accounting Fees	$11,500
Advertising & Promotion	$0
Information Technology Expenses	$0
Insurance Expenses	$0
Interest Expenses	$0
Investment Management Fees	$0
Legal Fees	$4,880
Pension Plan Contributions	$0
Professional Fundraising Expenses	$0

Revenue
Contributions	$846,469
Government Grants	$0
Program Services	$0
Investments	$871,671
Special Events	($124,276)
Sales	$0
Other	$0
Total Revenue	$1,593,864

Expenses
Program Services	$956,008
Administration	$55,922
Fundraising	$125,825
Total Expenses	$1,137,755
Net Gain/Loss	$456,109

Functional expenses
Accounting Fees	$11,500
Advertising & Promotion	$0
Information Technology Expenses	$0
Insurance Expenses	$0
Interest Expenses	$0
Investment Management Fees	$0
Legal Fees	$3,472
Pension Plan Contributions	$0
Professional Fundraising Expenses	$0

Revenue
Contributions	$751,356
Government Grants	$0
Program Services	$0
Investments	$581,128
Special Events	($103,753)
Sales	$0
Other	$0
Total Revenue	$1,228,731

Expenses
Program Services	$983,949
Administration	$57,502
Fundraising	$129,381
Total Expenses	$1,170,832
Net Gain/Loss	$57,899

Functional expenses
Accounting Fees	$12,000
Advertising & Promotion	$0
Information Technology Expenses	$0
Insurance Expenses	$0
Interest Expenses	$0
Investment Management Fees	$0
Legal Fees	$974
Pension Plan Contributions	$0
Professional Fundraising Expenses	$0

Revenue
Contributions	$721,746
Government Grants	$0
Program Services	$0
Investments	$731,972
Special Events	($33,452)
Sales	$0
Other	$0
Total Revenue	$1,420,266

Expenses
Program Services	$623,027
Administration	$57,184
Fundraising	$128,664
Total Expenses	$808,875
Net Gain/Loss	$611,391

Functional expenses
Accounting Fees	$11,500
Advertising & Promotion	$0
Information Technology Expenses	$0
Insurance Expenses	$0
Interest Expenses	$0
Investment Management Fees	$0
Legal Fees	$1,900
Pension Plan Contributions	$0
Professional Fundraising Expenses	$0

Revenue
Contributions	$498,933
Government Grants	$0
Program Services	$0
Investments	$611,059
Special Events	($13,670)
Sales	$0
Other	$0
Total Revenue	$1,096,322

Expenses
Program Services	$615,966
Administration	$59,963
Fundraising	$134,918
Total Expenses	$810,847
Net Gain/Loss	$285,475

Functional expenses
Accounting Fees	$13,000
Advertising & Promotion	$0
Information Technology Expenses	$0
Insurance Expenses	$0
Interest Expenses	$0
Investment Management Fees	$0
Legal Fees	$0
Pension Plan Contributions	$0
Professional Fundraising Expenses	$0

CANCER RESEARCH & TREATMENT FUND INC

Balance sheet

Fiscal Year: Jan 01 - Dec 31

SOURCE: IRS Form 990 info

The balance sheet gives a snapshot of the financial health of an organization at a particular point in time. An organization's total assets should generally exceed its total liabilities, or it cannot survive long, but the types of assets and liabilities must also be considered. For instance, an organization's current assets (cash, receivables, securities, etc.) should be sufficient to cover its current liabilities (payables, deferred revenue, current year loan, and note payments). Otherwise, the organization may face solvency problems. On the other hand, an organization whose cash and equivalents greatly exceed its current liabilities might not be putting its money to best use.

Fiscal year ending: Download Data

Assets	Jan 01, 2008	Dec 31, 2008	Change
Contributions	$254,704
Cash & Equivalents	$1,584,233	$935,624	($648,609)
Accounts Receivable	$0	$0	$0
Pledges & Grants Receivable	$0	$0	$0
Receivable, Other	$0	$0	$0
Inventories for Sale or Use	$0	$0	$0
Investment, Securities	$9,491,517	$9,109,998	($381,519)
Investment, Other	$0	$0	$0
Fixed Assets (LBE - Depreciation)	$16,600	$10,546	($6,054)
Other	$203,243	$186,222	($17,021)
Total Assets	$11,295,593	$10,242,390	($1,053,203)

Liabilities	Jan 01, 2008	Dec 31, 2008	Change
Accounts Payable	$889	$192	($697)
Grants Payable	$650,000	$600,000	($50,000)
Deferred Revenue	$0	$0	$0
Loans and Notes	$0	$0	$0
Tax-Exempt Bond Liabilities	$0	$0	$0
Other	$0	$0	$0
Total Liabilities	$650,889	$600,192	($50,697)

Fund balance	Jan 01, 2008	Dec 31, 2008	Change
Temporarily Restricted Net Assets	$0	$0	$0
Permanently Restricted Net Assets	$0	$0	$0
Total Restricted Net Assets	$0	$0	$0
Unrestricted Net Assets	$0	$0	$0
Net Assets	$10,644,704	$9,642,198	($1,002,506)

Assets	Jan 01, 2009	Dec 31, 2009	Change
Contributions	$185,001
Cash & Equivalents	$935,624	$467,388	($468,236)
Accounts Receivable	$0	$0	$0
Pledges & Grants Receivable	$0	$0	$0
Receivable, Other	$0	$0	$0
Inventories for Sale or Use	$0	$0	$0
Investment, Securities	$9,109,998	$9,523,609	$413,611
Investment, Other	$0	$0	$0
Fixed Assets (LBE - Depreciation)	$10,546	$16,676	$6,130
Other	$186,222	$31,954	($154,268)
Total Assets	$10,242,390	$10,039,627	($202,763)

Liabilities	Jan 01, 2009	Dec 31, 2009	Change
Accounts Payable	$192	$34,214	$34,022
Grants Payable	$600,000	$400,000	($200,000)
Deferred Revenue	$0	$0	$0
Loans and Notes	$0	$0	$0
Tax-Exempt Bond Liabilities	$0	$0	$0
Other	$0	$0	$0
Total Liabilities	$600,192	$434,214	($165,978)

Fund balance	Jan 01, 2009	Dec 31, 2009	Change
Temporarily Restricted Net Assets	$0	$0	$0
Permanently Restricted Net Assets	$0	$0	$0
Total Restricted Net Assets	$0	$0	$0
Unrestricted Net Assets	$0	$0	$0
Net Assets	$9,642,198	$9,605,413	($36,785)

Assets	Jan 01, 2010	Dec 31, 2010	Change
Contributions	$350,635
Cash & Equivalents	$467,388	$1,639,938	$1,172,550
Accounts Receivable	$0	$0	$0
Pledges & Grants Receivable	$0	$0	$0
Receivable, Other	$0	$0	$0
Inventories for Sale or Use	$0	$0	$0
Investment, Securities	$9,523,609	$8,942,826	($580,783)
Investment, Other	$0	$0	$0
Fixed Assets (LBE - Depreciation)	$16,676	$12,388	($4,288)
Other	$31,954	$36,242	$4,288
Total Assets	$10,039,627	$10,631,394	$591,767

Liabilities	Jan 01, 2010	Dec 31, 2010	Change
Accounts Payable	$34,214	$5,004	($29,210)
Grants Payable	$400,000	$400,000	$0
Deferred Revenue	$0	$0	$0
Loans and Notes	$0	$0	$0
Tax-Exempt Bond Liabilities	$0	$0	$0
Other	$0	$0	$0
Total Liabilities	$434,214	$405,004	($29,210)

CANCER RESEARCH & TREATMENT FUND INC

Financial trends analysis Glossary & formula definitions

Fiscal Year: Jan 01 - Dec 31

SOURCE: IRS Form 990 info

This snapshot of CANCER RESEARCH & TREATMENT FUND INC’s financial trends applies Nonprofit Finance Fund® analysis to data hosted by GuideStar. While it highlights the data that matter most, remember that context is key – numbers only tell part of any story.

Created in partnership with

Fiscal year: Jan 01 - Dec 31 View full report Download data

Business model indicators

Profitability	2017	2018	2019	2020	2021
Unrestricted surplus (deficit) before depreciation	$1,106,969	-$892,173	$1,534,474	$1,376,145	$975,455
As % of expenses	89.4%	-78.4%	131.2%	170.7%	120.5%
Unrestricted surplus (deficit) after depreciation	$1,106,447	-$892,173	$1,533,552	$1,373,378	$974,226
As % of expenses	89.3%	-78.4%	131.0%	169.8%	120.1%

Revenue composition
Total revenue (unrestricted & restricted)	$1,072,497	$1,593,864	$1,228,731	$1,420,266	$1,096,322
Total revenue, % change over prior year	17.7%	48.6%	-22.9%	15.6%	-22.8%
Program services revenue	0.0%	0.0%	0.0%	0.0%	0.0%
Membership dues	0.0%	0.0%	0.0%	0.0%	0.0%
Investment income	6.9%	5.7%	6.4%	8.7%	12.5%
Government grants	0.0%	0.0%	0.0%	0.0%	0.0%
All other grants and contributions	69.4%	45.3%	52.7%	48.5%	44.3%
Other revenue	23.7%	49.0%	40.9%	42.9%	43.2%

Expense composition
Total expenses before depreciation	$1,238,045	$1,137,755	$1,169,910	$806,108	$809,618
Total expenses, % change over prior year	9.3%	-8.1%	2.8%	-31.1%	0.4%
Personnel	8.8%	10.6%	11.0%	31.3%	33.3%
Professional fees	3.4%	2.7%	2.6%	4.8%	4.8%
Occupancy	3.0%	3.6%	3.5%	5.4%	5.3%
Interest	0.0%	0.0%	0.0%	0.0%	0.0%
Pass-through	78.1%	75.4%	75.5%	48.8%	47.2%
All other expenses	6.6%	7.7%	7.4%	9.7%	9.3%

Full cost components (estimated)	2017	2018	2019	2020	2021
Total expenses (after depreciation)	$1,238,567	$1,137,755	$1,170,832	$808,875	$810,847
One month of savings	$103,170	$94,813	$97,493	$67,176	$67,468
Debt principal payment	$0	$0	$0	$0	$0
Fixed asset additions	$0	$0	$8,300	$0	$0
Total full costs (estimated)	$1,341,737	$1,232,568	$1,276,625	$876,051	$878,315

Capital structure indicators

Liquidity	2017	2018	2019	2020	2021
Months of cash	5.1	11.9	9.8	38.4	14.2
Months of cash and investments	113.7	118.5	132.9	207.9	219.7
Months of estimated liquid unrestricted net assets	113.2	113.8	126.3	203.9	217.4

Balance sheet composition	2017	2018	2019	2020	2021
Cash	$522,836	$1,132,670	$957,889	$2,578,222	$957,332
Investments	$11,203,592	$10,102,091	$11,995,153	$11,386,420	$13,862,641
Receivables	$0	$5,000	$0	$0	$24,270
Gross land, buildings, equipment (LBE)	$86,931	$86,931	$95,231	$95,231	$95,231
Accumulated depreciation (as a % of LBE)	100.0%	100.0%	92.3%	95.2%	96.4%
Liabilities (as a % of assets)	0.3%	4.0%	5.0%	2.0%	1.3%
Unrestricted net assets	$11,683,850	$10,791,677	$12,325,229	$13,698,607	$14,672,833
Temporarily restricted net assets	$13,446	$13,447	N/A	N/A	N/A
Permanently restricted net assets	$0	$0	N/A	N/A	N/A
Total restricted net assets	$13,446	$13,447	$0	$0	$0
Total net assets	$11,697,296	$10,805,124	$12,325,229	$13,698,607	$14,672,833

Key data checks

Key data checks	2017	2018	2019	2020	2021
Material data errors	No	No	No	No	No

Operations

The people, governance practices, and partners that make the organization tick.

Documents

Letter of Determination is not available for this organization

Form 1023/1024 is not available for this organization

President

Thomas M. Silver

Number of employees

Source: IRS Form 990

CANCER RESEARCH & TREATMENT FUND INC

Officers, directors, trustees, and key employees

SOURCE: IRS Form 990

Compensation

Other

Show data for fiscal year

Compensation data

Download up to 5 most recent years of officer and director compensation data for this organization

CANCER RESEARCH & TREATMENT FUND INC

Highest paid employees

SOURCE: IRS Form 990

Compensation

Other

Show data for fiscal year

Compensation data

Download up to 5 most recent years of highest paid employee data for this organization

CANCER RESEARCH & TREATMENT FUND INC

Board of directors
as of 07/19/2023

SOURCE: Self-reported by organization

Board of directors data

Download the most recent year of board of directors data for this organization

Board chair

Mr. Tom Silver

Leadership Directories

Term: 2016 -

Board leadership practices

SOURCE: Self-reported by organization

GuideStar worked with BoardSource, the national leader in nonprofit board leadership and governance, to create this section.

Board orientation and education
Does the board conduct a formal orientation for new board members and require all board members to sign a written agreement regarding their roles, responsibilities, and expectations? No
CEO oversight
Has the board conducted a formal, written assessment of the chief executive within the past year ? No
Ethics and transparency
Have the board and senior staff reviewed the conflict-of-interest policy and completed and signed disclosure statements in the past year? No
Board composition
Does the board ensure an inclusive board member recruitment process that results in diversity of thought and leadership? No
Board performance
Has the board conducted a formal, written self-assessment of its performance within the past three years? No

Organizational demographics

SOURCE: Self-reported; last updated 8/17/2022

Candid has made improvements to the race and ethnicity options.

Who works and leads organizations that serve our diverse communities? Candid partnered with CHANGE Philanthropy on this demographic section.

Leadership

The organization's leader identifies as:

Race & ethnicity

White/Caucasian/European

Gender identity

Male

Disability status

Decline to state

Race & ethnicity

No data

Gender identity

No data

Sexual orientation

No data

Disability

No data

There are no contractors recorded for this organization.

Professional fundraisers

Fiscal year ending

SOURCE: IRS Form 990 Schedule G

Solicitation activities

Gross receipts from fundraising

Retained by organization

Paid to fundraiser

CANCER RESEARCH & TREATMENT FUND INC

Mission

Is this your nonprofit?

Programs and results

What we aim to solve

This profile needs more info.

Our programs

Grantmaking

Where we work

Financials

Financial documents

Revenue vs. expenses: breakdown

Liquidity in 2021 info

5.04

Months of cash in 2021 info

14.2

Fringe rate in 2021 info

9%

Funding sources info

Assets & liabilities info

Financial data

Digitizing IRS form 990 data

CANCER RESEARCH & TREATMENT FUND INC

CANCER RESEARCH & TREATMENT FUND INC

CANCER RESEARCH & TREATMENT FUND INC

Business model indicators

Capital structure indicators

Key data checks

Operations

Documents

President

Thomas M. Silver

Number of employees

CANCER RESEARCH & TREATMENT FUND INC

Compensation data

CANCER RESEARCH & TREATMENT FUND INC

Compensation data

CANCER RESEARCH & TREATMENT FUND INC

Board of directors data

Mr. Tom Silver

Board leadership practices

Board orientation and education

CEO oversight

Ethics and transparency

Board composition

Board performance

Organizational demographics

Leadership

Race & ethnicity

Gender identity

Sexual orientation

Disability

Professional fundraisers

Solicitation activities

Liquidity in 2021

Months of cash in 2021

Fringe rate in 2021

Funding sources

Assets & liabilities